Where ONS Voices Talk Cancer
Join oncology nurses on the Oncology Nursing Society’s award-winning podcast as they sit down to discuss the topics important to nursing practice and treating patients with cancer.
ISSN 2998-2308
php/*
Where ONS Voices Talk Cancer
Join oncology nurses on the Oncology Nursing Society’s award-winning podcast as they sit down to discuss the topics important to nursing practice and treating patients with cancer.
ISSN 2998-2308
Copyright: © Copyright 2017
"One of the things about futility is many people will say, 'Oh this is futile care,' when what they really mean is, 'Who in their right mind would want this?' or 'I would never ever want this,' and that's different. That's not futile care. That's potentially inappropriate care. And sometimes that's the big step for folks," Lucia D. Wocial, PhD, RN, FAAN, HEC-C, senior clinical ethicist in the John J. Lynch Center for Ethics at the MedStar Washington Hospital Center in Washington, DC, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about futile care: how to recognize it, how to approach communication during difficult situations, and how to address a nurse's associated ethical distress.
You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to futility in care and how to speak up for patients and prevent ethical distress.
Episode Notes
Oncology Nursing Podcast:
ONS Voice articles:
Clinical Journal of Oncology Nursing articles:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"It's a term that appeared in the literature back in the 1980s when it became clear that we had medical technology that could sustain people's lives but not actually return them to a healthy state. And so, there was this attempt to try and identify and define when it was that the care we were providing, the treatments we were providing, could no longer work. And so, some people tried 'qualitative futilities,' some people tried 'quantitative futility.' People have been working on it for a long time, but the shortest definition is a treatment intervention that will not have its intended effect." TS 1:52
"And first of all, it says futility is a definition that should be used sparingly. There are lots of times when a treatment may be considered what we call 'potentially inappropriate.' And when thinking about what's the difference between futility and potentially inappropriate? Futility is, it's clearly not going to work. Potentially inappropriate is, well, it might work, but there are lots of competing reasons why maybe we ought not to do it. And some of those reasons might be significant burden. Some of them may be the patient won't be able to achieve a neurologic state where they be able to actually perceive the benefit of ongoing biological existence. That statement, it has some very clear recommendations about: be very careful about how you use the words." TS 7:15
"In my work as a clinical ethicist, far and away the more frequent reason we get called is families want to keep going. It's not the other way around. And in fact, when a family or a patient is ready to stop, those become incredibly difficult for the healthcare team, particularly when there's a physician who feels like, 'But I know this will work. Don't not do this. You have a 50%, 60%, 70% chance of surviving. don't you want to try?' So to know that you have the ability to give them a chance is one thing." TS 13:33
"And here's the tragedy in this, and I hear oncologists say this, 'Well, it's not time yet.' That's my favorite response, it's, 'Not yet. Not yet.' So, when you ask most people, 'If you knew that you were going to die in the next three months, are there things that you would want to do before you die?' most people are like, 'Well yeah'. To fail to invite this conversation robs them of this choice." TS 16:04
"Step one: Don't keep it to yourself. A lot of it is making sure that you talk with other folks, and if you work in an inpatient setting and your hospital is Joint Commission certified, then there is some mechanism in place in your institution for dealing with an ethics challenge. But the idea is what we do is hard. And one of the biggest challenges for people who are experiencing ethics distress or moral distress is very rarely do ethical challenges happen when people are having a good time. There's a tragedy somewhere, and part of the big challenge is to separate the tragedy, like the cosmic unfairness, injustice, from 'Are we as a healthcare team contributing to the injustice?'" TS 40:51
"Reassuring doesn't always mean providing solutions. Sometimes, it's providing support. There are some key tips that can be helpful for supporting patients when they're ready, when they're asking, 'What about my kids?' Like, what are the things when you leave this hospital that your kids are going to see, hear, or notice? That's a great place to start," Kelsey Mora, certified child life specialist, licensed clinical professional counselor, and chief clinical officer at Pickles Group, a national nonprofit organization that provides support and resources to children and teens whose parents have cancer, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about how oncology nurses can support young families during a parent's cancer journey.
You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to supporting young family members during a parent's cancer journey.
Episode Notes
Oncology Nursing Podcast Episode 9: How to Support Adolescent and Young Adult Patients With Cancer
ONS Voice articles
ONS book: This Should Not Be Happening: Young Adults With Cancer
Anticancer Research article: Impact of Parental Cancer on Children
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"I think there's a concern that young kids won't understand or won't remember, and what we actually see is that even the youngest kids can really pick up on changes in their environment. So, when there's a cancer diagnosis, there is inevitably unavoidable change and disruption, whether it be to caregiving routines, availability, schedules, their appearance and ability status, hospitalizations, and certainly observed emotions. Kids are curious at all ages, so they pick up on things and they try to make sense of things on their own. And so, my role is really around helping nurses help parents and parents help their kids understand what's going on so that they're not left trying to figure it out on their own." TS 3:52
"Providing kids with honest and age-appropriate information is about providing them with a narrative to make sense of what's going on, and so it is honest, but it is age appropriate to kind of tailor it to the age or development of the child." TS 5:03
"Pickles Group was born out of finding families where kids were saying, you know, 'I want to meet other kids who can relate to this,' because the second there is a cancer diagnosis, they feel really different from their friends and their peers. And so being able to connect with others who can understand more of their experience is super important." TS 5:48
"I always tell parents that 'I don't know' is a real answer. That's an honest answer, right? Being able to say, 'You know, that's a great question. I don't know the answer right now, but as soon as I do, I'll definitely talk about it with you.'" TS 9:35
"I think it's so important to normalize that grief occurs the second that there is a diagnosis, because there is so much change and transition and loss and uncertainty. A lot of times for kids, that's just like the loss of the way things were before or the loss of being able to relate to peers or the loss of the things that my parent was able to do before or just them not being around as much." TS 16:32
"It's really important to look at where your target is and what the toxicities are associated with hitting that target. Make sure you include that thinking when you're talking about bispecifics," ONS member Rowena (Moe) Schwartz, PharmD, BCOP, professor of pharmacy practice at the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about the use of bispecific monoclonal antibodies in hematologic cancers and solid tumors.
You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to bispecific monoclonal antibodies in hematologic cancers and solid tumors.
Episode Notes
ONS resources for cytokine release syndrome
Oncology Nursing Podcast Episode 176: Oncologic Emergencies 101: Cytokine Release Syndrome
Clinical Journal of Oncology Nursing article: STAT: Cytokine Release Syndrome
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"When we talk about bispecifics, we need to really pay attention to both the target on the cancer and the target for T-cell engaging, because that impacts both efficacy but also toxicity." TS 4:20
"If you really look deep into the clinical trials, often the patients that are receiving these agents in clinical trials have had more than the required three or four lines of treatment. They may have had five or more lines of treatment. So it's really important to kind of look at where it sits right now, knowing, of course, that that's an evolving target." TS 7:13
"One of the things I think can be missed, at times, is the fact that you need to consider the toxicities associated with your target on the cancer cell." TS 10:06
"In terms of mitigating risk, there's been two major ways that have been done. One is a step-up dose schedule, and so one of the key things I would say: If you're not familiar with an agent that you're going to be administering, it's really important to review the entire step-up scheme because it's different for each agent. In some cases, patients need to be admitted to the hospital for the entire step-up strategy. Other times it's just the first dose. So it's really important to look at that." TS 11:58
"I think we're going to get to the point where our teaching strategy is going to have to be somewhat tailored to the agent we're giving. So, how the drug is given during the step-up, what the subsequent cycling is going to be, whether it's going to be a Q21-day cycle or a weekly dosing administration or every-two-week administration after a certain point. So, I think some understanding of what to expect going forward because these are drugs that are given continually in most situations and so it's important for people to know what to expect." TS 14:25
"I think we're going to see bispecifics that perhaps engage other aspects of the immune system besides CD3. In fact, those are in clinical trials. And I do believe that we're going to see these more and more developed for cancers beyond the hematologic malignancies. There's a lot of work being done at looking at targets that we know are helpful targets in certain cancers. And I think we'll see more drugs approved beyond the myeloma and the lymphoma and the leukemia space." TS 20:42
"You don't have to have any musical background to benefit from musical therapy," ONS member Susan Yaguda, MSN, RN, manager of integrative oncology and survivorship in the Department of Supportive Oncology at the Levine Cancer Institute in Charlotte, North Carolina, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about how music therapists and oncology nurses collaborate to offer music therapy's benefits to patients with cancer.
You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to the use of music therapy.
Episode Notes
ONS Voice articles:
What the Evidence Says About Music Therapy for Cancer-Related Fatigue
Music Therapy May Bridge Race-Related Gaps in Cancer Pain Management
Clinical Journal of Oncology Nursing article: Mindful Awareness of Music: A Modality for Symptom Management
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"A lot of people have their workout playlist or something that kind of pumps them up before they're going to go play a tennis match or something like that. But in using music in this way, there isn't really a specific therapeutic goal and the relationship in these situations. And while any of us can provide recorded music or live music to patients, certainly our care partners, if we're not trained as music therapists, it just should not be considered or referred to as music therapy." TS 3:56
"It might be using music to help regulate breath work, to reduce stress and anxiety associated with whatever they're having done in the suite. It can also be used as a distraction." TS 6:19
"Oftentimes after that point, our patients may be starting to experience some other troubling side effects or symptoms from their treatment or their cancer. The music therapist can help them with better manage those in a supportive way. And this can be done in things like techniques to help them manage pain, techniques to help them maybe destress and get more restful, sleep even." TS 7:00
"Sometimes using music as that tool helps create the space that does feel even more safe. It's not necessarily having to talk to someone directly, but music is the vehicle for doing that processing work." TS 15:01
"There is receptive music therapy. So that is basically where the person receiving music therapy is not co-creating music, or writing lyrics, or anything like that, they're just listening. There might just be some paced breathing exercises that are incorporated into this. It tends to be a more repetitive type of cadence to the music that can help create just being in a better zone if they're trying to and bring the anxiety level down." TS 16:16
"It's really an exciting time to be in the field of oncology because we can have these specific drugs that target these specific variants rather than, back in the day, when we had to use kind of generic cancer therapies that weren't specific for an individual's cancer," ONS member Suzanne Walker, PhD, CRNP, AOCN®, senior advanced practice provider and coordinator for thoracic malignancies at the Abramson Cancer Center at Penn Presbyterian Medical Center in Philadelphia, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about the latest updates in chemotherapy and immunotherapy treatments. Walker is one of the editors of ONS's second edition of the Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice book. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to updates in chemotherapy and immunotherapy.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"We've seen significant improvement in cancer survival over the past one to two decades. And primarily we've seen this not only from reductions in smoking and earlier cancer detection, but advancements in some of our treatments, most notably in the realm of immunotherapy and targeted therapy." Timestamp (TS) 02:07
"With the discovery of the biomarkers, it has brought around the discovery of genomic-driven therapies that are specific to these biomarkers. That's really changed the landscape of oncology for people that have one of these driver variants." TS 07:55
"I've definitely seen in my practice where therapy has been completed and, especially for some of these immunotherapy drugs, a couple of months later the patient develops a toxicity that is from the prior immunotherapy. Even chemotherapy can have some long-term toxicities, but we do have to even keep it in mind for immunotherapy that once these drugs are finished, there still could be some long-term side effects. Since they are newer drugs, we still are learning about what some of these long-term toxicities look like." TS 26:56
"There haven't been a ton of new FDA approvals specific for chemotherapy; however, we have seen chemotherapy still used in practice, particularly in combination with some of these novel therapies. Particularly, we see a lot of chemotherapy and immunotherapy combinations." TS 27:47
"Like all emergencies, they're unpredictable. I have seen them at the very beginning and sometimes, unfortunately, that can be the patient's first sign or symptom that they have cancer. It can be something like they've lost the ability to walk, or their breathing gets difficult. I've also seen it during the middle of their care continuum where we finish a round of radiation and they develop metastatic disease so the next time you see then for radiation can be for a cord compression. I've also seen it toward the end of their care continuum where this is strictly a quality-of-life measure," ONS member John Hollman, BSN, RN, OCN®, senior nurse manager of radiation oncology at AdventHealth Cancer Institute in Orlando, FL, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about radiation therapy for emergent and urgent interventions. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to radiation therapy when used in the emergent and urgent setting.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"It is a larger dose per day typically than you would give for six weeks. So, you want to give a lower dose per day if you're going to stretch it out for six to eight weeks. Shorter courses like these, for emergencies, are a higher dose per day but a short time frame of treatment." Timestamp (TS) 14:34
"As a nurse, I kind of like to overeducate, and you can kind of tell which patients are more receptive to knowing everything, and some of them want to know the bare minimum." TS 16:14
"The thing that's different with these patients is that sometimes those side effects will hit when they're no longer in your clinic." TS 17:19
"I say get to know your medical oncologists and your radiation oncologist. Communication can be open; it doesn't have to be a silo if you don't need it to be." TS 22:14
"The more educated the patient is, it lessens their nerves. I feel like the more educated they are, they know what to expect. They know every step of the process." TS 32:02
"These patients have very intense regimens of chemotherapy. They're tired a lot of the time. Between their oral chemotherapy, their IV chemotherapy, their hospitalizations, and then coming in. Everything takes longer than we would like it to for these patients. They are long days to come in for a procedure," ONS member Rebekah Rabinowitz, RN, BSN, OCN®, neuro-oncology nurse at Emory University Hospital in Atlanta, GA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, oncology clinical specialist at ONS, during a discussion about nursing considerations for intraventricular and intrathecal administration. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to antineoplastic administration via intraventricular and intrathecal routes.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"We're not actually giving the chemotherapy intrathecal or intraventricular, but we're there for the whole process. Handing the chemotherapy and the check off, the whole thing. We're monitoring them if they're sedated. We're making sure they're getting their antiemetics." Timestamp (TS) 12:31
"When we're doing teaching with the patient, we often do bring up that it's similar to when women get an epidural when they're having a baby. It's the same space that we're using. We're using a smaller needle, we're not leaving a catheter in, but pregnant people do it every day. That sort of helps ease a little anxiety when they think about it that way." TS 15:04
"You have to meet their medical literacy needs. They may not be aware that this administration route even exists." TS 21:42
"People think that it's going to be a painful procedure. It's uncomfortable, people don't like it, but it's not horribly painful. If we do see pain, that's concerning. It'll likely be an ER visit for imaging." TS 26:36
What is it like to guide a professional association that serves more than 100,000 oncology nurses? ONS Chief Executive Officer Brenda Nevidjon, MSN, RN, FAAN, and 2023–2026 Directors-at-Large Susan Brown, PhD, MSN, CENP, Jessica MacIntyre, DNP, MBA, APRN, AOCNP®, and Trey Woods, RN, MSN, NP-C, discuss the ONS Leadership Development Committee's appointment process for the ONS Board of Directors, reflect on their experience in ONS, and elaborate on the work they do in their leadership positions. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to the role of the ONS Board of Directors.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
Trey Woods: "An emphasis of my service really has been on lots of volunteer opportunities and lots of committee work, and I just feel like that's opened the door to me for so many great networking opportunities. I would certainly encourage anybody who's interested in leadership or volunteering to look into the multitude of opportunities that ONS makes available to the members." Timestamp (TS) 9:41
Jessica MacIntyre: "I really wanted to pay it forward, and I also want to continue to be a voice and advocate for our patients and members. And there's no better platform than ONS to take my advocacy to the next level. I couldn't be prouder to lead ONS in this role and to contribute to its mission of excellence in oncology nursing and transforming cancer care." TS 14:50
Jessica MacIntyre: "What struck me the most is the breadth and depth of issues we tackle. I think from policy to strategic initiatives, the agenda is truly dynamic, and it's been a testament to how every aspect of our profession can be a catalyst for change." TS 24:48
Susan Brown: "I'm just so impressed and inspired by the dedication and commitment of the people sitting around the ONS Board table." TS 31:27
Trey Woods: "When it comes to nursing burnout, I think the focus really needs to be on what is encouraging, because for all the things that concern me, I think that there's opportunity for encouragement. I think there's opportunities for organizations like ours to move nursing forward." TS 33:52
Susan Brown: "We keep having a lot of first-timers at ONS Congress®, and that just tells me that our job of educating oncology nurses of the future is a never-ending process." TS 37:22
"Since gastrointestinal complications are so broad, you will see these types of complications in really any oncology setting," ONS member Kara Freedman, MS, RN, AGCNS-BC, PCCN, OCN®, clinical nurse specialist in ambulatory GI surgery/medicine at Memorial Sloan Kettering Cancer Center in New York, NY, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, oncology clinical specialist at ONS, during a discussion about managing gastrointestinal complications. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to gastrointestinal symptom management.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"Preparing our patients, not scaring the daylights out of them, but preparing them for what to expect and really when to contact us, not to wait until it gets too severe so that it's even harder to treat. We really do want to make sure we're driving this home when we're educating our patients." Timestamp (TS) 17:52
"As nurses, we know dietary suggestions that we can give them, but if we are finding a patient needs a little more help, reaching out to our local dietician could really help benefit the patient in a positive way." TS 24:12
"It takes a village. You know, we are not siloed by ourselves caring for these patients. The patient will benefit from the more support that we give them." TS 39:05
"There are many other issues and problems that occur, other than nausea and vomiting, for these patients with cancer. This can not only affect their weight and their nutritional status but their overall quality of life as well. It's really important to make sure we are looking at the whole patient." TS 39:58
"If we're not driving our own research agenda and we're not asking the questions we see as important, we are not realizing the full potential of nursing. We know, because we are with patients, what the issues are for patients, for families, and for communities. We have to be able to say, 'Nope, this is the question.'" Margaret (Peg) Rosenzweig, PhD, FNP-BC, AOCNP®, ONS's scholar-in-residence and professor at the University of Pittsburgh in Pennsylvania, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, oncology clinical specialist at ONS, during a discussion about her oncology nursing clinical and research career, commitment to equity, and role as ONS's scholar-in-residence. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to race in research.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"A commitment that we all have to have is toward more diversity in oncology nursing and in oncology research and thinking about what can I do in my world." Timestamp (TS) 7:52
"Unless we listen to and really fully honor what the nurse can ask about their experience with patients, we're missing so much in the way that we can help patients' families and communities." TS 17:08
"I think we haven't thought fully enough about the patient in the context of their life. I think we've thought about symptoms, but we have to think about the patient baring those symptoms, where they come from, and what they've experienced. So, I think incorporating the social determinants of health is very important." TS 18:00
"White researchers will say, 'It doesn't matter. You can hire White recruiters and as long as people are properly trained, that should not matter.' I feel like that is a bit of implicit bias that we as White researchers just don't recognize. We think it doesn't matter because it doesn't matter to us. But it does matter to Black women." TS 30:13